Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Martin

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Cell Reports|April 19, 2018
Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial MigrationYvona Ward, Ross Lake, Farhoud Faraji, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
EJNMMI Radiopharmacy and Chemistry|February 6, 2026
A new <sup>68</sup>Ga-labeled dimeric FAP ligand to advance targeted PET imaging of cancerFeng Li, Chaitanya Kondam, Zhen Yang, et al.
Advanced Healthcare Materials|September 3, 2013
Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlationTom O McDonald, Marco Giardiello, Philip Martin, et al.
Journal for Immunotherapy of Cancer|March 8, 2018
Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysisKeith E Steele, Tze Heng Tan, René Korn, et al.
Oncotarget|April 22, 2017
Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasisYuan Yang, Howard H Yang, Ying Hu, et al.
AIDS (London, England)|September 16, 2015
Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activationDean J Naisbitt, Emma L Yang, Mohammad Alhaidari, et al.
Toxicology Letters|January 29, 2016
Toxicity and inflammatory response in Swiss albino mice after intraperitoneal and oral administration of polyurethane nanoparticlesAdny H Silva, Claudriana Locatelli, Fabíola B Filippin-Monteiro, et al.
Cancer Research|March 12, 2017
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple ImmunotherapiesJonathan Rios-Doria, Jay Harper, Raymond Rothstein, et al.
JCI Insight|February 8, 2022
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLCEric Tu, Kelly McGlinchey, Jixin Wang, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Cell Reports|April 19, 2018
Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial MigrationYvona Ward, Ross Lake, Farhoud Faraji, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
EJNMMI Radiopharmacy and Chemistry|February 6, 2026
A new <sup>68</sup>Ga-labeled dimeric FAP ligand to advance targeted PET imaging of cancerFeng Li, Chaitanya Kondam, Zhen Yang, et al.
Advanced Healthcare Materials|September 3, 2013
Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlationTom O McDonald, Marco Giardiello, Philip Martin, et al.
Journal for Immunotherapy of Cancer|March 8, 2018
Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysisKeith E Steele, Tze Heng Tan, René Korn, et al.
Oncotarget|April 22, 2017
Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasisYuan Yang, Howard H Yang, Ying Hu, et al.
AIDS (London, England)|September 16, 2015
Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activationDean J Naisbitt, Emma L Yang, Mohammad Alhaidari, et al.
Toxicology Letters|January 29, 2016
Toxicity and inflammatory response in Swiss albino mice after intraperitoneal and oral administration of polyurethane nanoparticlesAdny H Silva, Claudriana Locatelli, Fabíola B Filippin-Monteiro, et al.
Cancer Research|March 12, 2017
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple ImmunotherapiesJonathan Rios-Doria, Jay Harper, Raymond Rothstein, et al.
JCI Insight|February 8, 2022
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLCEric Tu, Kelly McGlinchey, Jixin Wang, et al.
Pageof 10